Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
Speaker 2: The Stock Movers Report, your roundup of companies making moves
Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
Speaker 3: Let's take a look at some stocks on the move
Speaker 3: today in Europe. I'm Stephen Carroll with Tom McKenzie and
Speaker 3: we're joined by Bloomberg reporter Chloe Melee. Chloe, good morning.
Speaker 3: Let's start then with the mining company Fresnillo gaining this morning.
Speaker 3: Tell us more.
Speaker 4: Yeah, a couple of positive things for Fresnela this morning.
Speaker 1: So first of all, it got upgraded to a bio
Speaker 1: rating by HSBC, and it's also benefiting from a real
Speaker 1: big rally in gold and silver. So silver hit the
Speaker 1: highest level in decades because a short squeeze in London
Speaker 1: boosted what was already a really massive rally this year.
Speaker 1: And then gold, which last week saw a little bit
Speaker 1: of a dip because of traders exiting their positions to
Speaker 1: kind of lock in those profits, have suched again to
Speaker 1: another record. And because Fresnio operates both gold and silver mines,
Speaker 1: when there is a lot of bester enthusiasm around those
Speaker 1: precious metals, it's always really reflected in the shares. You know,
Speaker 1: shares in Fresno are up more than three hundred percent
Speaker 1: a year today.
Speaker 4: It's been seeing a really massive rally.
Speaker 1: The trade tensions in the US government shutdown have driven
Speaker 1: this rush towards safe Haven. So this may continue because
Speaker 1: we get we've gotten now further US China attention.
Speaker 4: The US government shutdown is still ongoing, so.
Speaker 1: We're likely to see a continuation of this and that
Speaker 1: will be benefit.
Speaker 4: Presnio are going forward.
Speaker 3: And in the drug space, Astro Seneca rebounding struting a
Speaker 3: deal with the Trumpe administration.
Speaker 4: What are the details and how significant is this hook
Speaker 4: for that company?
Speaker 1: It is quite significant, So it will be cutting prices
Speaker 1: on some of its key drugs in exchange for a
Speaker 1: bit of tariff relief. So this follows essentially the template
Speaker 1: that we saw with Paiza a couple of weeks ago.
Speaker 1: The deal means that asha Zeneca will launch all of
Speaker 1: its new medicines in the US at the lowest prices
Speaker 1: that were offered to other countries, and it also provides
Speaker 1: medicines to the Medicaid health insurance program at highly discounted prices.
Speaker 1: It will also expand the number of products sold through
Speaker 1: its direct to consumer website at what Trump described as
Speaker 1: heavily reduced costs, and also make those medicines available on
Speaker 1: the trump Arex website once it launches, which is this
Speaker 1: platform that will launched in early twenty twenty six where
Speaker 1: American consumers will be able to buy prescription drugs directly
Speaker 1: from those pharmaceutical companies. So this is not the first
Speaker 1: time that AstraZeneca has been really proactive and trying to
Speaker 1: appease Trump. We remember that it was one of the
Speaker 1: first companies to announce a major investment in manufacturing facilities
Speaker 1: in the US. The plan is for fifty billion dollars
Speaker 1: of that investment in the country, and you know this
Speaker 1: will put probably pressure on other drug makers to continue
Speaker 1: into in that path and to make those very similar
Speaker 1: deals with Trump as well going forward.
Speaker 3: Okay, and next to the front, cable manufacturer Exiles dropping
Speaker 3: those shows after announcing and UCEO.
Speaker 1: Yeah, so it's a surprise exit of the CEO effective immediately.
Speaker 1: So JP Morgan said that the management shakeup came as
Speaker 1: a big surprise because it comes just a couple of
Speaker 1: months after the announcement that the deputy CEO and the
Speaker 1: CFO would be stepping down as well. They said that
Speaker 1: the outgoing CEO had been an outspoken CEO who had
Speaker 1: completely transformed the equity story of Nixon's, so it seems
Speaker 1: that there was a lot of confidence in that CEOs.
Speaker 4: Desparture is not really welcomed.
Speaker 1: JP Morgan analysts also said that the new CEO, Julia Hooper,
Speaker 1: is a new face and therefore they didn't really know
Speaker 1: how he is going to perform. Just last week, the
Speaker 1: company had another tough day as well because it got
Speaker 1: downgraded by BNP Parabaut, with the analysting that they expect
Speaker 1: a really massive deceleration of earnings growth from next year.
Speaker 1: So there seems to be quite a lot of turmoil
Speaker 1: here for Nexceens, and this management shakeup is not.
Speaker 4: Being received very warmly by the market, it seems.
Speaker 2: The stock mover's report from Bloomberg Radio check back with
Speaker 2: us throughout the day for the latest roundup of companies
Speaker 2: making news on Wall Street and for the latest market
Speaker 2: moving had lines. Listen to Bloomberg Radio Live, catch us
Speaker 2: on YouTube, Bloomberg dot com, and on Applecarplay and Android
Speaker 2: Auto with the Bloomberg Business app.